期刊文献+

CXCR4抑制剂与抗血管内皮生长因子抗体联合应用对实验性脉络膜新生血管形成的干预作用 被引量:5

Inhibitory effect of CXCR4 inhibitor combined with anti-vascular endothelial growth factor antibody on experimental choroidal neovascularization
原文传递
导出
摘要 目的观察玻璃体腔联合注射CXCR4抑制剂AMD3100与抗血管内皮生长因子(VEGF)抗体对实验性脉络膜新生血管(CNV)形成的干预作用。方法选取48只棕色挪威(BN)大鼠随机分为AF564干预实验组(A组)、AMD3100干预实验组(B组)、联合干预实验组(c组)、磷酸盐缓冲液(PBS)对照组(D组),每组均为12只大鼠,左眼为实验眼。采用氪红激光光凝建立CNV模型。激光光凝后即刻玻璃体腔分别注射抗鼠VEGF抗体(AF564)、CXCR4特异性抑制剂AMD3100、抗鼠VEGF抗体及AMD3100、PBS各5μl。激光光凝后14d行荧光素眼底血管造影(FFA),病理组织切片及脉络膜血管铺片检查。观察不同组别大鼠荧光渗漏程度以及CNV相对厚度和面积的变化。结果激光光凝后14d,A、B、C、D组荧光渗漏评分分别为2.16±0.91、2.16±0.91、1.92±1.03、1.39±0.93。A、B、C组荧光渗漏较D组荧光渗漏明显受抑制,差异均有统计学意义(F=12.91,P〈0.001);C组荧光渗漏程度低于A、B组,差异有统计学意义(F=9.21,P〈O.05)。组织病理学检查显示,激光光凝后14d,A、B、C、D组CNV相对厚度分别为1.82士0.11、1.90±0.22、1.12±0.12、2.82±0.29。A、B、C组相对CNV厚度与D组CNV相对厚度比较,差异均有统计学意义(F=5.92,P〈O.001);C组CNV相对厚度明显变薄,与A、B组CNV相对厚度比较,差异均有统计学意义(F=5.16,P〈0.05)。脉络膜血管铺片结果显示,A、B、C、D组CNV面积分别为(8204±122)、(9332±211)、(6533土101)、(13644±255)μm2。A、B、C组cNV面积较D组cNV面积明显减少,差异均有统计学意义(F=147.50,P〈0.001);C组CNV面积与A、B组CMV面积比较,差异有统计学意义(F=112.60,P〈0.05)。结论CXCR4抑制剂及抗VEGF抗体联合使用,可显著抑制激光诱导的CNV形成。 Objective To observe the effects of CXCR4 inhibitor (AMD3100) combined with anti- vascular endothelial growth factor (VEGF) antibody on experimental choroidal neovascularization. Methods Choroidal neovascularization (CNV) was induced in 48 Brown-Norway (BN) rats by Krypton red laser photocoagulation, and those rats were randomly divided into AF564 group (group A), AMD3100 group (group B), combined treatment group (group C) and PBS group (group D), 12 rats in each group. Left eyes were the experimental eyes. The rats of group A - D received intravitreal injection of 5μl of AF564, AMD3100, AF564/AMD3100 and PBS after laser photocoagulation respectively. Fourteen days after photocoagulation, fundus fluorescein angiography (FFA), pathological section analysis and choroidal vascular wholemount were used to observe the degree of fluorescein leakage, the relative thickness and areas of CNV. Results Fourteen days after photocoagulation, the scores of fluorescein leakage in group A - D were 2.16±0.91, 2.16±0.91, 1.92±1.03, 1.39±0.93 respectively. Fluorescein leakage in group A - C was obviously reduced compared to group D (F= 12.91, P〈0. 001), while fluorescein leakage in group C was reduced compared to group A and B (F=9.21 ,P〈0.05). The CNV relative thicknesses in group A-D were 1.82±0.11, 1.90±0.22, 1.12±0.12, 2.82±0.29 respectively. Group A-C had thinner CNV compared to group D (F=5.92,P〈0. 001), while group C had thinner CNV compared to group A and B (F=5.16, P〈0.05). The CNV areas in group A- D were (8204±122), (9332±211), (6533±101), and (13644±255) μm2 respectively. Group A - C had smaller CNV area compared to group D (F=147.50,P〈 0.001), while group C had smaller CNV area compared to group A and B (F=112.60, P〈0.05). Conclusion Combined treatment with CXCR4 inhibitor and anti-VEGF antibody can inhibit laser-induced CNV significantly.
出处 《中华眼底病杂志》 CAS CSCD 北大核心 2011年第6期553-556,共4页 Chinese Journal of Ocular Fundus Diseases
基金 国家“973计划”一级子课题(2011CB707506) 国家自然科学基金(30973259)
关键词 脉络膜新生血管化/治疗 受体 CXCR4/药物作用 血管内皮生长因子类 趋化因子CXCL12 疾病模型 动物 Choroidal neovascularization/therapy Receptors, CXCR4/ drug effects Vascular endothelial growth factors Chemokine CXCL12 Disease models, animal
  • 相关文献

参考文献21

  • 1Klein R, Peto T, Bird A, et al. The epidemiology of age-related macular degeneration. Am J Ophthalmol, 2004,137 : 486-495.
  • 2戴虹,杨絮,喻晓兵,龙力,黄林英.抗血管内皮生长因子单克隆抗体Ranibizumab治疗渗出型老年性黄斑变性临床观察[J].中华眼底病杂志,2008,24(3):160-163. 被引量:25
  • 3Brown DM, Kaiser PK, Michels M, et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med,2006,355: 1432-1444.
  • 4Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med, 2006,355: 1419-1431.
  • 5Waltenberger J. VEGF resistance as a molecular basis to explain the angiogenesis paradox in diabetes mellitus, Biochem Soc Trans,2009,37: 1167 -1170.
  • 6Lima E, Silva R, Shen J, et al. The SDF-1/CXCR4 ligand/ receptor pair is an important contributor to several types of ocular neovascularization. FASEB J,2007, 21 : 3219-3230.
  • 7赵世红,何守志.氪激光诱导的大鼠脉络膜新生血管模型研究[J].中华眼科杂志,2003,39(5):298-302. 被引量:38
  • 8Lee E, Rewolinski D. Evaluation of CXCR4 inhibition in the prevention and intervention model of laser-induced choroidal neovascularization. Invest Ophthalmol Vis Sci, 2010,51 : 3666 3672.
  • 9Takehana Y, Kurokawa T, Kitamura T, et al. Suppression of laser induced choroidal neovaseularization by oral tranilast in the rat. Invest Ophthalmol Vis Sei,1999,40:459 -466.
  • 10Berglin L, Sarman S, van der Ploeg I, et al. Reduced choroidal neovascular membrane formation in matrix metalloproteinase-2 deficient mice. Invest Ophthalmol Vis Sci,2003,44:403 -408.

二级参考文献46

共引文献85

同被引文献87

引证文献5

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部